Table 1.
Detection of the anti-Trichinella IgG antibodies in sera from patients infected with Trichinella spp. by commercial ELISA and home ELISA.
Fig 1.
SDS-PAGE analysis of muscle larvae (ML) excretory-secretory proteins of T. spiralis (E-S T1) and T. britovi (E-S T3).
Fig 2.
The immunoblot analysis of A) T. spiralis and B) T. britovi E-S ML proteins incubated with Trichinella-infected human sera samples (lanes 1–9), and the negative control samples (lanes 10 and 11). The red box indicates the area with the highest differences in the immunoblot patterns between Trichinella species. Signal intensity and relative migration values of T. spiralis (C) and T. britovi (D) ML E-S with Trichinella-infected sera (analysis of lane 6).
Fig 3.
An image of 2-DE separations and immunoblot analysis of T. spiralis and T. britovi E-S ML proteins.
A-T. spiralis, C-T. britovi—2-DE gels were stained with silver stain; 2D-immunoblot of T. spiralis (B) and T. britovi (D) proteins were probed with infected human sera at 14 dpi. Matched spots selected for subsequent LC-MS/MS analysis are marked.
Table 2.
Results of LC-MS/MS analysis of selected spots from Trichinella spiralis muscle larvae excretory-secretory proteins which reacted with Trichinella-infected human serum.
Table 3.
Results of LC-MS/MS analysis of selected spots from Trichinella britovi muscle larvae excretory-secretory proteins which reacted with Trichinella-infected human serum.
Table 4.
GO categories of T. spiralis immunoreactive E-S ML proteins.
Table 5.
GO categories of T. britovi immunoreactive E-S ML proteins.